SCHEMBL381695

SCHEMBL381695

CC(=O)NCC(c1cccc(C(F)(F)F)c1)N(C(=O)O)C(C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.43
OPRL1 P41146 1/20 0.43
BCHE P06276 2/20 0.42
NPC1 O15118 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP1A2 P05177 1/20 0.41
POLB P06746 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
KMT2A Q03164 1/20 0.41
GPR139 Q6DWJ6 1/20 0.41
KDM4E B2RXH2 1/20 0.41
TACR1 P25103 2/20 0.40
CES2 O00748 1/20 0.40
ACP3 P15309 1/20 0.40
PPARG P37231 2/20 0.39
SLC22A12 Q96S37 1/20 0.39
ATM Q13315 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19244872 0.88 OPRM1 (0.48) OPRM1OPRL1BCHENPC1SMN1; SMN2
SCHEMBL381593 0.85 BCHE (0.41) OPRM1OPRL1BCHESMN1; SMN2MEN1
SCHEMBL380987 0.84 ALDH1A1 (0.40) OPRM1OPRL1BCHESMN1; SMN2MEN1
SCHEMBL381185 0.84 ACP3 (0.47) SMN1; SMN2MEN1ALDH1A1CYP1A2POLB
SCHEMBL15170368 0.84 ACP3 (0.47) SMN1; SMN2MEN1ALDH1A1CYP1A2POLB
SCHEMBL381880 0.83 SMN1; SMN2 (0.42) OPRM1OPRL1BCHESMN1; SMN2MEN1
SCHEMBL16674214 0.83 PNMT (0.52) SMN1; SMN2MEN1ALDH1A1CYP1A2POLB
SCHEMBL414657 0.83 ACP3 (0.43) SMN1; SMN2MEN1ALDH1A1CYP1A2POLB
SCHEMBL16715280 0.80 TACR1 (0.44) BCHESMN1; SMN2MEN1ALDH1A1CYP1A2
SCHEMBL19244815 0.80 ACP3 (0.40) SMN1; SMN2MEN1ALDH1A1CYP1A2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2408751-B1 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof BAYER IP GMBH (DE) 2017-08-23 EP disclosed
EP-2408751-A1 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof Bayer Pharma Aktiengesellschaft (DE) 2012-01-25 EP disclosed
WO-2010105770-A1 SUBSTITUTED 2-ACETAMIDO-5-ARYL-1,2,4-TRIAZOLONES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-09-23 WO disclosed